UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 14, 2011

 

Cephalon, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware

 

0-19119

 

23-2484489

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

41 Moores Road Frazer, Pennsylvania

 

19355

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  ( 610) 344-0200

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2.):

 

o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

 

Item 5.07   Submission of Matters to a Vote of Security Holders.

 

At a special meeting of stockholders of Cephalon, Inc. (the “Company”) held on July 14, 2011 (the “Special Meeting”), the Company’s stockholders approved the proposal to adopt the Agreement and Plan of Merger, dated May 1, 2011 (as it may be amended from time to time, the “Merger Agreement”), by and among the Company, Teva Pharmaceutical Industries Ltd., an Israeli corporation (“Parent”), and Copper Acquisition Corp., a Delaware corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”). The Merger Agreement provides for the merger of Merger Sub with and into the Company, with the Company surviving as an indirect wholly-owned subsidiary of Parent. Because the holders of a majority of the outstanding shares approved the proposal to adopt the Merger Agreement, Proposal No. 2, entitled “Approval of the Adjournment of the Special Meeting to a Later Date,” was tabled.  The holders of a majority of the shares present or represented at the Special Meeting by proxy and entitled to vote approved the non-binding proposal regarding certain merger-related executive compensation arrangements.

 

Each proposal is described in detail in the proxy statement dated June 14, 2011 and first mailed to the Company’s stockholders on June 14, 2011.  The proposals were approved by the Company’s stockholders at the Special Meeting.  Stockholders owning a total of 60,616,589 shares voted at the Special Meeting, representing approximately 78% of the shares of the Company’s common stock outstanding as of the record date for the Special Meeting. A summary of the voting results for each proposal is set forth below:

 

Proposal to Adopt the Merger Agreement:

 

FOR

 

AGAINST

 

ABSTAIN

 

60,565,945

 

32,446

 

18,198

 

 

Proposal to Adjourn the Special Meeting:

 

Proposal to adopt the Merger Agreement was approved and this proposal was tabled.

 

Non-Binding Proposal to Adopt Certain Merger-Related Executive Compensation Arrangements:

 

FOR

 

AGAINST

 

ABSTAIN

 

52,979,933

 

6,176,229

 

1,460,427

 

 

Item 8.01   Other Events

 

On July 14, 2011, the Company issued a press release announcing that the majority of its shares have been voted to approve the proposed Merger Agreement.   A press release is furnished as Exhibit 99.1 to this report and is incorporated herein.

 

2



 

Item 9.01    Financial Statements and Exhibits.

 

(d)           Exhibits

 

Exhibit No.

 

Description of Exhibit

 

 

 

99.1

 

Press Release of Cephalon, Inc. dated July 14, 2011

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CEPHALON, INC.

 

 

 

 

 

 

Date: July 14, 2011

By:

/s/ Gerald J. Pappert

 

 

Gerald J. Pappert

 

 

Executive Vice President, General Counsel and Secretary

 

4



 

EXHIBIT INDEX

 

Exhibit No.

 

Description of Exhibit

99.1

 

Press Release of Cephalon, Inc. dated July 14, 2011

 

5


Cephalon (NASDAQ:CEPH)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Cephalon.
Cephalon (NASDAQ:CEPH)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Cephalon.